Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| DENTSPLY SIRONA Inc.XRAY · Entity 4448 | Director | January 09, 2026 | January 13, 2026 |
| G1 Therapeutics, Inc.GTHX · Entity 87413 | Director | June 23, 2022 | June 24, 2022 |
| Merck & Co., Inc.MRK · Entity 2807 | Exe V-P & Pres. MMD | February 22, 2016 | February 24, 2016 |
| PUBLIC SERVICE ENTERPRISE GROUP INCPEG · Entity 203 | Director | May 01, 2026 | May 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
DENTSPLY SIRONA Inc.
Report date January 09, 2026 · Filed January 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 57,748.066 |
Reported balance
After 2026-01-09 transaction · row 1
1 source rowRow 1 · 2026-01-09 · Grant · Acquired 201.508 · Balance 57,748.066 F1: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis.
G1 Therapeutics, Inc.
Report date June 23, 2022 · Filed June 24, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 14,389 |
Reported balance
After 2022-06-23 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2022-06-23 · Grant · Acquired 10,000 · Balance 14,389 F1: Represents a restricted stock unit ("RSU") award that vests in its entirety twelve months after June 23, 2022, subject to the Reporting Person's continued service as a director. F2: Each RSU represents a contingent right to receive one share of Issuer common stock F3: Represents 4,389 shares of common stock and 10,000 restricted stock units |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $5.30 · Expires 2032-06-23 | Direct | 30,000 |
Reported balance
After 2022-06-23 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-06-23 · Grant · Acquired 30,000 · Balance 30,000 F4: The shares underlying this option will vest in their entirety twelve months after June 23, 2022, subject to the Reporting Person's continued service as a director. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a restricted stock unit ("RSU") award that vests in its entirety twelve months after June 23, 2022, subject to the Reporting Person's continued service as a director.
F2: Each RSU represents a contingent right to receive one share of Issuer common stock
F3: Represents 4,389 shares of common stock and 10,000 restricted stock units
F4: The shares underlying this option will vest in their entirety twelve months after June 23, 2022, subject to the Reporting Person's continued service as a director.
Merck & Co., Inc.
Report date February 22, 2016 · Filed February 24, 2016
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 133,759.3521 |
Reported balance
After 2016-02-22 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2016-02-22 · Grant · Acquired 14,557 · Balance 133,759.3521 F1: Distribution of net after tax shares of common stock on satisfaction of performance share units granted on 03/29/2013. Performance shares were paid out at 105 percent of target awards. F2: Holdings include shares acquired in dividend reinvestment transactions. |
| Common Stock - 401(k) PlanSEC Table I · non-derivative | IndirectBy 401(k) | 719.079 |
Reported balance
Holding disclosure · report date 2016-02-22 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 719.079 F3: Includes shares acquired and dividends earned through January 8, 2016, in the Merck U.S. Savings Plan, a 401(k) plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Distribution of net after tax shares of common stock on satisfaction of performance share units granted on 03/29/2013. Performance shares were paid out at 105 percent of target awards.
F2: Holdings include shares acquired in dividend reinvestment transactions.
F3: Includes shares acquired and dividends earned through January 8, 2016, in the Merck U.S. Savings Plan, a 401(k) plan.
PUBLIC SERVICE ENTERPRISE GROUP INC
Report date May 01, 2026 · Filed May 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 11,933.239 |
Reported balance
After 2026-05-01 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-05-01 · Grant · Acquired 2,246 · Balance 11,933.239 F1: 2026 Restricted Stock Unit grant under the PSEG 2021 Equity Compensation Plan For Outside Directors. F2: Amount includes accumulated dividend reinvestment equivalents that are exempt from Section 16. |
Filing footnotes · ownership attribution and instrument terms
F1: 2026 Restricted Stock Unit grant under the PSEG 2021 Equity Compensation Plan For Outside Directors.
F2: Amount includes accumulated dividend reinvestment equivalents that are exempt from Section 16.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
CDK Global, Inc.
Report date July 06, 2022 · Filed July 06, 2022
Section 16 reporting ended · disclosed 2022-07-06. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2022-07-06 transaction · row 1
1 source rowRow 1 · 2022-07-06 · Disposition to issuer · Disposed 31,684 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), among the Company, Central Parent LLC ("Parent") and Central Merger Sub Inc. ("Merger Sub"), on July 6, 2022, Merger Sub merged with and into the Company, with the Company surviving the merger as a wholly owned subsidiary of Parent (the "Merger"), and, at the effective time of the Merger, each share of common stock, par value $0.01 per share (each, a "Share"), of the Company was canceled and converted into the right to receive $54.87 in cash without interest. |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $39.67 | Direct | 0 |
Reported balance
After 2022-07-06 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-07-06 · Disposition to issuer · Disposed 15,384 · Balance 0 F2: Pursuant to the Merger Agreement, each option outstanding immediately prior to the consummation of the Merger, whether then unvested or vested, by virtue of the Merger and without any action by the holder, was canceled and converted into only the right to receive an amount in cash, without interest, equal to the product of (x) the number of Shares issuable under such option and (y) the excess, if any, of (i) $54.87 over (ii) the exercise price payable in respect of each Share issuable under such option (the "Option Consideration"); provided, however, that the Option Consideration for each option with an exercise price equal to or greater than $54.87 was $0. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), among the Company, Central Parent LLC ("Parent") and Central Merger Sub Inc. ("Merger Sub"), on July 6, 2022, Merger Sub merged with and into the Company, with the Company surviving the merger as a wholly owned subsidiary of Parent (the "Merger"), and, at the effective time of the Merger, each share of common stock, par value $0.01 per share (each, a "Share"), of the Company was canceled and converted into the right to receive $54.87 in cash without interest.
F2: Pursuant to the Merger Agreement, each option outstanding immediately prior to the consummation of the Merger, whether then unvested or vested, by virtue of the Merger and without any action by the holder, was canceled and converted into only the right to receive an amount in cash, without interest, equal to the product of (x) the number of Shares issuable under such option and (y) the excess, if any, of (i) $54.87 over (ii) the exercise price payable in respect of each Share issuable under such option (the "Option Consideration"); provided, however, that the Option Consideration for each option with an exercise price equal to or greater than $54.87 was $0.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 21, 2020 Filed May 22, 2020 20:15 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 4,766 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-017750 · form4.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,954.583 F1 · shares: This grant consists entirely of Restricted Stock Units (RSUs) that vest in full (restrictions lapse) one year from date of grant. Read SEC document |
| May 01, 2020 Filed May 5, 2020 01:33 UTC | PUBLIC SERVICE ENTERPRISE GROUP INC PEG · Entity 203 | GrantRestricted Stock Units · Derivative | 2,733 | $49.41 | $135,037.53 |
DisclosureSEC source: 0001225208-20-007046 · doc4.xml · derivative · entry 1 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,691.6866 Underlying: Common Stock · 2,733 shares Expires not disclosed F1 · derivative.exercise_price: Restricted Stock Units convert to common stock on a one-for-one basis. Restricted Stock Units represent the share equivalent of amount granted, with payment deferred, under the Equity Compensation Plan For Directors. F2 · kind: Restricted Stock Units are subject to forfeiture if a director leaves service and are paid in shares of common stock after termination of service. F3 · derivative.exercise_date: The derivative, Restricted Stock Units, do not have a corresponding exercisable date nor expiration date. F3 · derivative.expiration_date: The derivative, Restricted Stock Units, do not have a corresponding exercisable date nor expiration date. F4 · balance_after: Amount includes accumulated dividend reinvestment equivalents that are exempt from Section 16. Read SEC document |
| April 10, 2020 Filed Apr 14, 2020 20:08 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 8.629 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-013688 · form4.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,188.583 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| January 10, 2020 Filed Jan 14, 2020 21:27 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 5.748 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-001548 · form4.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,179.954 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| November 20, 2019 Filed Nov 23, 2019 00:03 UTC | CDK Global, Inc. CDK · Entity 125554 | GrantCommon Stock | 3,511 | $0.00 | $0.00 |
DisclosureSEC source: 0000950142-19-002340 · es1901270_4-deese.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,918 F1 · shares: The reported transaction reflects the grant of Restricted Stock Units under the Issuer's 2014 Omnibus Award Plan and represents a like number of shares of the Issuer's common stock. These Restricted Stock Units vest in full at the earlier of November 20, 2020 and the Issuer's next annual meeting of stockholders. Upon vesting these Restricted Stock Units will be deferred and settled in shares of the Issuer's common stock 180 days after the date the Reporting Person ceases to be a member of the Issuer's board of directors. Read SEC document |
| October 11, 2019 Filed Oct 16, 2019 20:13 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 6.167 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-030612 · form4.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,174.206 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| July 12, 2019 Filed Jul 16, 2019 20:30 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 4.882 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-024623 · form4.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,168.039 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| June 12, 2019 Filed Jun 14, 2019 20:35 UTC | G1 Therapeutics, Inc. GTHX · Entity 87413 | GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $18.47 | $0.00 |
DisclosureSEC source: 0001209191-19-037152 · doc4.xml · derivative · entry 1 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2029-06-12 F1 · derivative.exercise_date: The shares underlying this option will vest in their entirety twelve months after June 12, 2019, subject to the Reporting Person's continued service as a director. Read SEC document |
| May 24, 2019 Filed May 29, 2019 20:47 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 3,256 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-020153 · form4.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,163.157 F1 · shares: This grant consists entirely of Restricted Stock Units (RSUs) that vest in full (restrictions lapse) one year from date of grant. Read SEC document |
| May 01, 2019 Filed May 2, 2019 21:11 UTC | PUBLIC SERVICE ENTERPRISE GROUP INC PEG · Entity 203 | GrantRestricted Stock Units · Derivative | 2,297 | $58.78 | $135,017.66 |
DisclosureSEC source: 0001225208-19-007601 · doc4.xml · derivative · entry 1 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,555.6826 Underlying: Common Stock · 2,297 shares Expires not disclosed F1 · derivative.exercise_price: Restricted Stock Units convert to common stock on a one-for-one basis. Restricted Stock Units represent the share equivalent of amount granted, with payment deferred, under the Equity Compensation Plan For Directors. F2 · kind: Restricted Stock Units are subject to forfeiture if a director leaves service and are paid in shares of common stock after termination of service. F3 · derivative.exercise_date: The derivative, Restricted Stock Units, do not have a corresponding exercisable date nor expiration date. F3 · derivative.expiration_date: The derivative, Restricted Stock Units, do not have a corresponding exercisable date nor expiration date. F4 · balance_after: Amount includes accumulated dividend reinvestment equivalents that are exempt from Section 16. Read SEC document |
| April 12, 2019 Filed Apr 15, 2019 20:10 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 3.343 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-015439 · form4.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,907.157 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| January 11, 2019 Filed Jan 15, 2019 21:21 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 4.458 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-002003 · form4.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,903.814 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| November 13, 2018 Filed Nov 15, 2018 22:39 UTC | CDK Global, Inc. CDK · Entity 125554 | GrantCommon Stock | 3,266 | $0.00 | $0.00 |
DisclosureSEC source: 0000950142-18-002252 · ownership.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,407 F1 · shares: The reported transaction reflects the grant of Restricted Stock Units under the Issuer's 2014 Omnibus Award Plan and represents a like number of shares of the Issuer's common stock. These Restricted Stock Units vest in full at the earlier of November 13, 2019 and the Issuer's next annual meeting of stockholders. Upon vesting these Restricted Stock Units will be deferred and settled in shares of the Issuer's common stock 180 days after the date the Reporting Person ceases to be a member of the Issuer's board of directors. Read SEC document |
| October 12, 2018 Filed Oct 16, 2018 20:11 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 4.372 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-030305 · form4.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,899.356 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| July 13, 2018 Filed Jul 13, 2018 20:13 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 3.762 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-023191 · form4.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,894.984 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| June 07, 2018 Filed Jun 11, 2018 15:47 UTC | G1 Therapeutics, Inc. GTHX · Entity 87413 | GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $38.39 | $0.00 |
DisclosureSEC source: 0001209191-18-036859 · doc4.xml · derivative · entry 1 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2028-06-07 F1 · derivative.exercise_date: The shares underlying this option will vest in equal monthly installments over a period of three years, subject to the Reporting Person's continued service as a director. Read SEC document |
| May 23, 2018 Filed May 24, 2018 21:14 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantStock Option (Right to Buy) · Derivative | 8,500 | $0.00 Strike: $46.50 | $0.00 |
DisclosureSEC source: 0001127602-18-018819 · form4.xml · derivative · entry 2 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,500 Underlying: Common Stock · 8,500 shares Expires 2028-05-23 F2 · derivative.exercise_date: Stock Options vest in full one (1) year from date of grant. Read SEC document |
| May 23, 2018 Filed May 24, 2018 21:14 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 1,882 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-018819 · form4.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,891.222 F1 · shares: This grant consists entirely of Restricted Stock Units (RSUs) that vest in full (restrictions lapse) one year from date of grant. Read SEC document |
| May 01, 2018 Filed May 2, 2018 18:59 UTC | PUBLIC SERVICE ENTERPRISE GROUP INC PEG · Entity 203 | GrantRestricted Stock Units · Derivative | 2,604 | $51.86 | $135,043.44 |
DisclosureSEC source: 0001225208-18-008487 · doc4.xml · derivative · entry 1 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,955.8454 Underlying: Common Stock · 2,604 shares Expires not disclosed F1 · derivative.exercise_price: Restricted Stock Units convert to common stock on a one-for-one basis. Restricted Stock Units represent the share equivalent of amount granted, with payment deferred, under the Equity Compensation Plan For Directors. F2 · kind: Restricted Stock Units are subject to forfeiture if a director leaves service and are paid in shares of common stock after termination of service. F3 · derivative.exercise_date: The derivative, Restricted Stock Units, do not have a corresponding exercisable date nor expiration date. F3 · derivative.expiration_date: The derivative, Restricted Stock Units, do not have a corresponding exercisable date nor expiration date. F4 · derivative.underlying_shares: Amount includes accumulated dividend reinvestment equivalents that are exempt from Section 16. Read SEC document |
| April 13, 2018 Filed Apr 13, 2018 20:22 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 2.436 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-014544 · form4.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,009.222 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| January 12, 2018 Filed Jan 16, 2018 22:41 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 1.859 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-001878 · form4.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,006.786 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| November 15, 2017 Filed Nov 17, 2017 22:16 UTC | CDK Global, Inc. CDK · Entity 125554 | GrantCommon Stock | 2,467 | $0.00 | $0.00 |
DisclosureSEC source: 0000950142-17-002064 · es1701149_4-deese.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,141 F1 · shares: The reported transaction reflects the grant of Restricted Stock Units under the Issuer's 2014 Omnibus Award Plan and represents a like number of shares of the Issuer's common stock. These Restricted Stock Units vest in full at the earlier of November 15, 2018 and the Issuer's next annual meeting of stockholders. Upon vesting these Restricted Stock Units will be deferred and settled in shares of the Issuer's common stock 180 days after the date the Reporting Person ceases to be a member of the Issuer's board of directors. Read SEC document |
| October 13, 2017 Filed Oct 17, 2017 21:15 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 2.044 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-029956 · form4.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,004.927 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| July 14, 2017 Filed Jul 18, 2017 20:35 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 1.883 | $0.00 | $0.00 |
DisclosureSEC source: 0001246360-17-002364 · form.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,002.883 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| May 25, 2017 Filed May 26, 2017 21:49 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | Exercise / conversionRSU (Restricted Stock Unit) · Derivative | 1,220 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001246360-17-002034 · form.xml · derivative · entry 4 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2.015 Underlying: Common Stock · 1,220 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Restricted Stock Units (RSUs) convert into Common Stock on a one-for-one basis for no additional consideration. F4 · shares: Comprised of one thousand two hundred fourteen (1,214) vested RSUs plus six (6) RSUs accrued through dividend equivalent rights, each as previously reported in this Table II. F5 · derivative.exercise_date: Restricted Stock Units vest in full one (1) year from date of grant. F5 · derivative.expiration_date: Restricted Stock Units vest in full one (1) year from date of grant. Read SEC document |
| May 25, 2017 Filed May 26, 2017 21:49 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | Exercise / conversionCommon Stock | 1,220 | $0.00 | $0.00 |
DisclosureSEC source: 0001246360-17-002034 · form.xml · nonDerivative · entry 2 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,001 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 24, 2017 Filed May 26, 2017 21:49 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantStock Option (Right to Buy) · Derivative | 7,300 | $0.00 Strike: $62.73 | $0.00 |
DisclosureSEC source: 0001246360-17-002034 · form.xml · derivative · entry 3 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,300 Underlying: Common Stock · 7,300 shares Expires 2027-05-24 F2 · derivative.exercise_date: Stock Options vest in full one (1) year from date of grant. Read SEC document |
| May 24, 2017 Filed May 26, 2017 21:49 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 1,395 | $0.00 | $0.00 |
DisclosureSEC source: 0001246360-17-002034 · form.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,781 F1 · shares: This grant consists entirely of Restricted Stock Units (RSUs). Read SEC document |
| May 22, 2017 Filed May 23, 2017 20:14 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | Exercise / conversionRSU (Restricted Stock Unit) · Derivative | 1,601 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001246360-17-001992 · form.xml · derivative · entry 6 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,222.015 Underlying: Common Stock · 1,601 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted Stock Units (RSUs) convert into Common Stock on a one-for-one basis for no additional consideration. F6 · shares: Comprised of one thousand five hundred sixty-seven (1,567) vested RSUs plus thirty-four (34) RSUs accrued through dividend equivalent rights, each as previously reported in this Table II. F5 · derivative.exercise_date: Restricted Stock Units vest in full three (3) years from date of grant. F5 · derivative.expiration_date: Restricted Stock Units vest in full three (3) years from date of grant. Read SEC document |
| May 22, 2017 Filed May 23, 2017 20:14 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | Exercise / conversionCommon Stock | 1,601 | $0.00 | $0.00 |
DisclosureSEC source: 0001246360-17-001992 · form.xml · nonDerivative · entry 3 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,386 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 21, 2017 Filed May 23, 2017 20:14 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | Exercise / conversionRSU (Restricted Stock Unit) · Derivative | 1,412 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001246360-17-001992 · form.xml · derivative · entry 5 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,823.015 Underlying: Common Stock · 1,412 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted Stock Units (RSUs) convert into Common Stock on a one-for-one basis for no additional consideration. F4 · shares: Comprised of one thousand three hundred ninety (1,390) vested RSUs plus twenty-two (22) RSUs accrued through dividend equivalent rights, each as previously reported in this Table II. F5 · derivative.exercise_date: Restricted Stock Units vest in full three (3) years from date of grant. F5 · derivative.expiration_date: Restricted Stock Units vest in full three (3) years from date of grant. Read SEC document |
| May 21, 2017 Filed May 23, 2017 20:14 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | Exercise / conversionCommon Stock | 1,412 | $0.00 | $0.00 |
DisclosureSEC source: 0001246360-17-001992 · form.xml · nonDerivative · entry 2 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,785 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 20, 2017 Filed May 23, 2017 20:14 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | Exercise / conversionRSU (Restricted Stock Unit) · Derivative | 1,441 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001246360-17-001992 · form.xml · derivative · entry 4 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,235.015 Underlying: Common Stock · 1,441 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted Stock Units (RSUs) convert into Common Stock on a one-for-one basis for no additional consideration. F2 · shares: Comprised of one thousand four hundred twenty-six (1,426) vested RSUs plus fifteen (15) RSUs accrued through dividend equivalent rights, each as previously reported in this Table II. F3 · derivative.exercise_date: Restricted Stock Units vest in full one year from date of grant. F3 · derivative.expiration_date: Restricted Stock Units vest in full one year from date of grant. Read SEC document |
| May 20, 2017 Filed May 23, 2017 20:14 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | Exercise / conversionCommon Stock | 1,441 | $0.00 | $0.00 |
DisclosureSEC source: 0001246360-17-001992 · form.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,373 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 01, 2017 Filed May 3, 2017 20:43 UTC | PUBLIC SERVICE ENTERPRISE GROUP INC PEG · Entity 203 | GrantRestricted Stock Units · Derivative | 3,089 | $43.71 | $135,020.19 |
DisclosureSEC source: 0001225208-17-009051 · doc4.xml · derivative · entry 1 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,124.5855 Underlying: Common Stock · 3,089 shares Expires not disclosed F1 · derivative.exercise_price: Restricted Stock Units convert to common stock on a one-for-one basis. Restricted Stock Units represent the share equivalent of amount granted, with payment deferred, under the Equity Compensation Plan For Directors. F2 · date: Restricted Stock Units are subject to forfeiture if a director leaves service and are paid in shares of common stock after termination of service. F3 · derivative.exercise_date: The derivative, Restricted Stock Units, do not have a corresponding exercisable date nor expiration date. F3 · derivative.expiration_date: The derivative, Restricted Stock Units, do not have a corresponding exercisable date nor expiration date. F4 · balance_after: Includes accrued dividend equivalent unit reinvestment, including amounts previously accrued but not reflected in the total shown in previous filings. Read SEC document |
| April 14, 2017 Filed Apr 18, 2017 20:49 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantRSU (Restricted Stock Unit) · Derivative | 7.942 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001246360-17-001611 · form.xml · derivative · entry 1 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,676.015 Underlying: Common Stock · 7.942 shares Expires not disclosed F1 · derivative.exercise_price: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. F1 · derivative.exercise_date: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. F1 · derivative.expiration_date: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| January 13, 2017 Filed Jan 17, 2017 21:49 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantRSU (Restricted Stock Unit) · Derivative | 7.598 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001246360-17-000190 · form.xml · derivative · entry 1 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,668.073 Underlying: Common Stock · 7.598 shares Expires not disclosed F1 · derivative.exercise_price: Represents dividends on restricted stock units (RSUs) awarded to the reporting person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the reporting person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. F1 · derivative.exercise_date: Represents dividends on restricted stock units (RSUs) awarded to the reporting person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. F1 · derivative.expiration_date: Represents dividends on restricted stock units (RSUs) awarded to the reporting person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| November 15, 2016 Filed Nov 17, 2016 23:39 UTC | CDK Global, Inc. CDK · Entity 125554 | GrantCommon Stock | 2,587 | $0.00 | $0.00 |
DisclosureSEC source: 0000950142-16-004785 · es1601143_4-deese.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,674 F1 · shares: The reported transaction reflects the grant of Restricted Stock Units under the Issuer's 2014 Omnibus Award Plan and represents a like number of shares of the Issuer's common stock. These Restricted Stock Units vest in full at the earlier of November 15, 2017 or the Issuer's next annual meeting of stockholders. Upon vesting these Restricted Stock Units will be deferred and settled in shares of the Issuer's common stock 180 days after the date the Reporting Person ceases to be a member of the Issuers's board of directors. Read SEC document |
| October 14, 2016 Filed Oct 18, 2016 20:42 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantRSU (Restricted Stock Unit) · Derivative | 7.372 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001246360-16-006975 · form.xml · derivative · entry 1 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,662.475 Underlying: Common Stock · 7.372 shares Expires not disclosed F1 · derivative.exercise_price: Represents dividends on restricted stock units (RSUs) awarded to the reporting person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the reporting person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. F1 · derivative.exercise_date: Represents dividends on restricted stock units (RSUs) awarded to the reporting person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. F1 · derivative.expiration_date: Represents dividends on restricted stock units (RSUs) awarded to the reporting person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| May 23, 2016 Filed Oct 28, 2016 20:14 UTC Amendment | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | Exercise / conversionCommon Stock · Derivative | 1,748 | $0.00 | $0.00 |
DisclosureSEC source: 0001246360-16-007014 · form.xml · derivative · entry 2 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,435.965 Underlying: Common Stock · 1,748 shares Expires 2016-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Comprised of one thousand seven hundred ten (1,710) vested Restricted Stock Units (RSUs) plus thirty-eight (38) DERs. The original Form 4 reported all RSUs and thirty-six (36) DERs. RSUs convert into common stock on a 1:1 basis for no additional consideration. F1 · shares: This amended Form 4 is filed solely for the purpose of reporting an aggregate of two (2) additional shares of common stock which were accrued through dividend equivalent rights (DERs) and not reported on the original Form 4. F2 · shares: Comprised of one thousand seven hundred ten (1,710) vested Restricted Stock Units (RSUs) plus thirty-eight (38) DERs. The original Form 4 reported all RSUs and thirty-six (36) DERs. RSUs convert into common stock on a 1:1 basis for no additional consideration. Read SEC document |
| May 23, 2016 Filed Oct 28, 2016 20:14 UTC Amendment | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | Exercise / conversionCommon Stock | 1,748 | $0.00 | $0.00 |
DisclosureSEC source: 0001246360-16-007014 · form.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,932 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This amended Form 4 is filed solely for the purpose of reporting an aggregate of two (2) additional shares of common stock which were accrued through dividend equivalent rights (DERs) and not reported on the original Form 4. F2 · shares: Comprised of one thousand seven hundred ten (1,710) vested Restricted Stock Units (RSUs) plus thirty-eight (38) DERs. The original Form 4 reported all RSUs and thirty-six (36) DERs. RSUs convert into common stock on a 1:1 basis for no additional consideration. Read SEC document |
| February 22, 2016 Filed Feb 24, 2016 17:37 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantCommon Stock | 14,557 | $50.77 | $739,058.89 |
DisclosureSEC source: 0001225208-16-027757 · doc4.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Exe V-P & Pres. MMD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,759.3521 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance share units granted on 03/29/2013. Performance shares were paid out at 105 percent of target awards. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 02, 2015 Filed May 5, 2015 20:46 UTC | Merck & Co., Inc. MRK · Entity 2807 | Exercise / conversionRestricted Stock Unit · Derivative | 7,636 | $59.86 | $457,090.96 |
DisclosureSEC source: 0001225208-15-011272 · doc4.xml · derivative · entry 5 Deese Willie A · CIK 0001328766 · Exe V-P & Pres. MMD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,636 shares Expires 2015-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 02, 2015 Filed May 5, 2015 20:46 UTC | Merck & Co., Inc. MRK · Entity 2807 | Tax withholdingCommon Stock | 3,438 | $59.86 | $205,798.68 |
DisclosureSEC source: 0001225208-15-011272 · doc4.xml · nonDerivative · entry 2 Deese Willie A · CIK 0001328766 · Exe V-P & Pres. MMD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,193.0118 F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 02, 2015 Filed May 5, 2015 20:46 UTC | Merck & Co., Inc. MRK · Entity 2807 | Exercise / conversionCommon Stock | 7,636 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-15-011272 · doc4.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Exe V-P & Pres. MMD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,631.0118 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 01, 2015 Filed May 5, 2015 20:46 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantStock Option (right to buy) · Derivative | 99,071 | $0.00 Strike: $59.86 | $0.00 |
DisclosureSEC source: 0001225208-15-011272 · doc4.xml · derivative · entry 4 Deese Willie A · CIK 0001328766 · Exe V-P & Pres. MMD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,071 Underlying: Common Stock · 99,071 shares Expires 2025-04-30 F3 · derivative.exercise_date: The option vests and becomes exercisable in three equal installments on 5/1/2016, 5/1/2017 and 5/1/2018. Read SEC document |
| February 23, 2015 Filed Feb 25, 2015 16:27 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantCommon Stock | 8,762 | $58.30 | $510,824.60 |
DisclosureSEC source: 0001225208-15-005602 · doc4.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Exe V-P & Pres. MMD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,992.2077 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 03/30/2012. Performance shares were paid out at 102 percent of target awards. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 11, 2015 Filed Feb 11, 2015 19:19 UTC | Merck & Co., Inc. MRK · Entity 2807 | Exercise / conversionStock Option (right to buy) · Derivative | 48,144 | $0.00 Strike: $33.49 | $0.00 |
DisclosureSEC source: 0001225208-15-003523 · doc4.xml · derivative · entry 8 Deese Willie A · CIK 0001328766 · Exe V-P & Pres. MMD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,346 Underlying: Common Stock · 48,144 shares Expires 2020-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option became exercisable in equal installments on 5/7/2011, 5/7/2012 and 5/7/2013. Read SEC document |
| February 11, 2015 Filed Feb 11, 2015 19:19 UTC | Merck & Co., Inc. MRK · Entity 2807 | Exercise / conversionStock Option (right to buy) · Derivative | 34,680 | $0.00 Strike: $44.19 | $0.00 |
DisclosureSEC source: 0001225208-15-003523 · doc4.xml · derivative · entry 7 Deese Willie A · CIK 0001328766 · Exe V-P & Pres. MMD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 34,680 shares Expires 2017-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option became exercisable in equal installments on 3/2/2008, 3/2/2009 and 3/2/2010. Read SEC document |
| February 11, 2015 Filed Feb 11, 2015 19:19 UTC | Merck & Co., Inc. MRK · Entity 2807 | Exercise / conversionStock Option (right to buy) · Derivative | 53,040 | $0.00 Strike: $44.30 | $0.00 |
DisclosureSEC source: 0001225208-15-003523 · doc4.xml · derivative · entry 6 Deese Willie A · CIK 0001328766 · Exe V-P & Pres. MMD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 53,040 shares Expires 2018-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option became exercisable in equal installments on 2/28/2009, 2/28/2010 and 2/28/2011. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.